Benefits Benefits

Identifying Diabetic Complications Through Real-World Biomechanics

Benefits Benefits

Identifying Diabetic Complications Through Real-World Biomechanics

Diabetic foot ulcers (DFUs) are a leading cause of hospitalization and limb loss in people with diabetes.

But before the skin breaks down, the body gives signals—in how we walk.

Baliston captures those biomechanical signals in everyday life using smart insoles and advanced gait analysis. The result: early detection, proactive care, and fewer complications.

Key Metrics Key Metrics

What We Monitor

Symmetry-Index

Gaitline & Foot Biomechanics

Track propulsion changes, irregular foot paths, and imbalances linked to ulcer risk.

Cadence-Trends

Neuropathy Indicators

Detect early warning signs like reduced toe-off, timing shifts, and inconsistent stride patterns.

foot-pattern

Fall Risk Factors

Monitor stride variability, clearance reduction, and stability loss in real-life walking.

Muscle-Engagement

Activity & Adherence

Follow step count, intensity, and adherence to care recommendations—all remotely.

Benefit Benefit

Benefits for Providers

  • Dashboard with real-time metrics and trends
  • Ulcer risk scoring based on biomechanics and behavior
  • Deviation alerts from patient-specific baseline
  • RTM-ready reporting for reimbursement and clinical documentation
  • Fully remote care capability with FDA-registered technology

Example Alert:
"Asymmetry and reduced toe-off detected — ulcer risk increasing."

Benefit Benefit

Benefits for Patients

  • Receive in-app messages like:
    "Try shorter walks more often — stride length has dropped 10% this week."
  • Stay informed and engaged between visits
  • Reduce clinic visits with confidence and control over their care

Walk safely, with peace of mind

How How

How it Works?

  • Patient wears Baliston smart insoles daily (comfortable, <4mm thick and washable)
  • Movement data automatically captured during walking
  • Insights delivered to the provider via a secure dashboard
  • Alerts triggered if risk markers are detected
  • Reports support clinical decision-making and RTM billing
Reimbursement Reimbursement

Reimbursement Support for RPM

Baliston’s remote monitoring solution is designed to support clinical workflows while aligning with current CPT® billing codes in the U.S. healthcare system. Providers may be eligible to bill for the services below when deploying our platform for ongoing diabetic foot monitoring and ulcer risk prevention.

CPT® 99453

Initial setup and patient onboarding for remote monitoring of physiologic parameters (e.g., weight, pulse oximetry, respiratory data, etc.). Includes device setup and education.

Billing Frequency:

One-time; requires at least 16 days of data within a 30-day period

CPT® 99454

Device supply and data transmission for remote monitoring of physiologic metrics. Covers daily recordings and/or alert-based data capture.

Billing Frequency:

Once per 30-day period

CPT® 99457

First 20 minutes of remote treatment management, including interactive communication with the patient or caregiver. Must be provided by clinical staff or a qualified healthcare professional.

Billing Frequency:

Per calendar month (for first 20 minutes of RPM-related clinical time)

CPT® 99458

Each additional 20 minutes of RPM management time beyond the first 20 minutes, including patient/caregiver interaction.

Billing Frequency:

For every extra 20-minute increment within a calendar month

Post-Surgical Validation

Clinically Validated. Medically Trusted.

Baliston's in-clinic assessments are grounded in clinically proven sensor-based technology and algorithms used in published research, and real-world testing with over 200 million steps analyzed.

Clinical Technology Validation

Our gait analysis platform is powered by technology that has been validated in peer-reviewed studies, demonstrating over 95% accuracy versus lab-based gait systems.

Diabetes-Specific Validation

Clinical studies in diabetic populations using this technology have confirmed strong correlations between gait asymmetry, stride length, propulsion, foot progression angle, clearance, and gaitline deviation with increased risk of foot ulceration—supporting earlier, data-driven intervention in at-risk patients.